AEROSOL DELIVERY OF A BETA-GALACTOSIDASE ADENOVIRAL VECTOR TO THE LUNGS OF RODENTS

被引:40
作者
KATKIN, JP
GILBERT, BE
LANGSTON, C
FRENCH, K
BEAUDET, AL
机构
[1] BAYLOR COLL MED,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77030
[2] BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030
[3] BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030
[4] HOWARD HUGHES MED INST,HOUSTON,TX 77030
关键词
D O I
10.1089/hum.1995.6.8-985
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aerosol delivery of adenoviral vectors is of particular interest in regard to gene therapy for cystic fibrosis (CF), with potential advantages of more uniform respiratory delivery, a less invasive approach, and ease of repetition, The AdHCMVsp1LacZ (AdLacZ) adenoviral vector was used to evaluate the feasibility of aerosol delivery to the respiratory epithelium in rodents, The adenoviral vector tolerated aerosol generation as measured by recovery in an all-glass impinger, Using an Andersen sampler to mimic the human respiratory tract, aerosol particles were found to have an average mass mean aerodynamic diameter of 1.6 mu m and a geometric standard deviation of 1.7 mu m. Cotton rats and mice exposed to viral aerosols demonstrated beta-galactosidase expression in up to 10-30% of the epithelial surface of the small and large airways, whereas expression in Sprague Dawley rats was largely limited to the alveolar epithelium, Transgene expression was distributed uniformly through both lungs in animals treated by aerosol. The variables for aerosol delivery are complex and include viral titer, aerosol device, duration of exposure, species of recipient, and respiratory behavior among other factors, Species differences in expression in airways as compared to alveolar epithelium have important implications for clinical application.
引用
收藏
页码:985 / 995
页数:11
相关论文
共 49 条
[1]   NEW SAMPLER FOR THE COLLECTION, SIZING, AND ENUMERATION OF VIABLE AIRBORNE PARTICLES [J].
ANDERSEN, AA .
JOURNAL OF BACTERIOLOGY, 1958, 76 (05) :471-484
[2]  
BOUT A, 1994, GENE THER, V1, P385
[3]   LUNG GENE-THERAPY - IN-VIVO ADENOVIRUS-MEDIATED GENE-TRANSFER TO RHESUS-MONKEY AIRWAY EPITHELIUM [J].
BOUT, A ;
PERRICAUDET, M ;
BASKIN, G ;
IMLER, JL ;
SCHOLTE, BJ ;
PAVIRANI, A ;
VALERIO, D .
HUMAN GENE THERAPY, 1994, 5 (01) :3-10
[4]  
CAPLEN NJ, 1994, GENE THER, V2, P1
[5]  
CORKERY K J, 1988, Respiratory Care, V33, P676
[6]  
COTTEN M, 1993, METHOD ENZYMOL, V217, P618
[7]   ADMINISTRATION OF AN ADENOVIRUS CONTAINING THE HUMAN CFTR CDNA TO THE RESPIRATORY-TRACT OF INDIVIDUALS WITH CYSTIC-FIBROSIS [J].
CRYSTAL, RG ;
MCELVANEY, NG ;
ROSENFELD, MA ;
CHU, CS ;
MASTRANGELI, A ;
HAY, JG ;
BRODY, SL ;
JAFFE, HA ;
EISSA, NT ;
DANEL, C .
NATURE GENETICS, 1994, 8 (01) :42-51
[8]   HIGH-EFFICIENCY GENE-TRANSFER MEDIATED BY ADENOVIRUS COUPLED TO DNA-POLYLYSINE COMPLEXES [J].
CURIEL, DT ;
WAGNER, E ;
COTTEN, M ;
BIRNSTIEL, ML ;
AGARWAL, S ;
LI, CM ;
LOECHEL, S ;
HU, PC .
HUMAN GENE THERAPY, 1992, 3 (02) :147-154
[9]   INVESTIGATION INTO DEPOSITION OF INHALATION AEROSOL-PARTICLES AS A FUNCTION OF AIR-FLOW RATE IN A MODIFIED KIRK LUNG [J].
DAVIES, PJ ;
HANLON, GW ;
MOLYNEUX, AJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (12) :908-911
[10]   CORRECTION OF THE CYSTIC-FIBROSIS DEFECT INVITRO BY RETROVIRUS-MEDIATED GENE-TRANSFER [J].
DRUMM, ML ;
POPE, HA ;
CLIFF, WH ;
ROMMENS, JM ;
MARVIN, SA ;
TSUI, LC ;
COLLINS, FS ;
FRIZZELL, RA ;
WILSON, JM .
CELL, 1990, 62 (06) :1227-1233